Juq-446

JUQ-446 represents a potent addition to the library of novel tryptamines. While it offers interesting possibilities for neuropharmacological research, the lack of long-term clinical data presents significant risks regarding its unsanctioned use. Regulatory bodies are advised to monitor its prevalence to prevent public health crises associated with unregulated NPS markets.

JUQ-446 (hypothetical nomenclature representative of a specific substituted tryptamine) belongs to the broader class of indole alkaloids. Juq-446